From the Wall Street Journal's new health blog:
Drug companies have long said the high prices of medicines reflect the costly and risky process of bringing them from the lab to the clinic. Now, at least one executive has publicly added a second reason for the high prices: People are willing to pay.
Read more here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment